CYChongjie Yao

Chongjie Yao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chongjie Yao has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Source-Specific Extracellular Vesicle Functions and Engineering Strategies for Chronic Pain Management: A Comprehensive Review

    by Chongjie Yao, Jiayang Yu, Dong Xie, Shuaipan Zhang, Jiming Tao, Lingjun Kong, Lei Fang, Qingguang Zhu, Min Fang

    Chronic pain management faces significant limitations due to adverse effects and insufficient long-term relief from existing therapies. Extracellular vesicles (EVs) are lipid bilayer‐enclosed particles naturally carrying proteins, nucleic acids, and metabolites. Recently, EVs have emerged as a potential alternative approach. This review examines EVs from mesenchymal stem cells, neural cells, macrophages, and gut microbiota. EV activity is then assessed across the three major pain types defined by the ICD‑11: nociceptive pain, neuropathic pain, and nociplastic pain. We elucidate how source-specific EVs dynamically regulate different kinds of pain through multi-modal mechanisms, including neural signal transduction, neuroimmune axis coordination, structural neural repair, and metabolic network reprogramming. Furthermore, we discuss how these inherent therapeutic properties can be augmented through engineering approaches such as surface modification and cargo encapsulation, which enhance targeting and payload delivery. By integrating mechanistic insights into source‑specific EV functions with emerging engineering strategies, this review may provide a rational framework for developing next‑generation EV‑based analgesics. We conclude that harnessing the innate biological properties of EVs, complemented by strategic engineering, represents a potential non-opioid strategy for precise and effective management of chronic pain.


  • Open Access

    Efficacy and Safety of Massage Therapy for Cognitive Impairment in Patients With Autism Spectrum Disorder: Protocol for a Systematic Review and Meta-Analysis

    by Yi Zhong, Sijie Dang, Xiaoqiu Wang, Xin Yun Chia, Jing Zhang, Weijiang Li, Chongjie Yao, Zhengyu Li, Bin Xiao

    Background: Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by social communication deficits and cognitive impairment. As pharmacological and behavioral treatments often show inconsistent efficacy, massage therapy—a low-risk complementary approach including tuina and acupressure—is used to improve cognitive symptoms, yet its systematic efficacy and safety remain unevaluated. Objective: This systematic review and meta-analysis aims to evaluate the efficacy and safety of massage therapy (categorized into traditional Chinese medicine–based and Western-based approaches) for improving specific cognitive domains (eg, executive function, attention, and memory) in individuals with ASD. Methods: Randomized controlled trials (RCTs) and cluster RCTs will be identified across 9 English and Chinese databases (including PubMed, Cochrane Library, and China National Knowledge Infrastructure) through September 2025. Two reviewers will independently perform study selection, data extraction, and risk-of-bias assessment using version 2 of the Cochrane risk-of-bias tool. A random-effects model will be primarily applied due to anticipated clinical diversity, with fixed-effects models reserved for sensitivity analyses of homogeneous data ( I 2 =0%). Subgroup analyses will explore age, intervention context, and massage type. Evidence for primary outcomes—including checklist scores and specialized cognitive scales—will be assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Results: Selection results will be summarized in a PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram. This review will synthesize evidence on massage therapy’s effects on cognitive outcomes measured using scales such as the Autism Behavior Checklist, Childhood Autism Rating Scale, and Autism Treatment Evaluation Checklist, as well as safety profiles. This study was funded in 2024. Following the September 2025 search, analysis will be completed by June 2026, with final results expected for submission in December 2026. Conclusions: This study will evaluate massage therapy’s role in managing cognitive impairment in ASD. By synthesizing available evidence from RCTs, the findings will provide an evidence-based foundation for clinical decision-making and clarify whether manual therapies serve as safe, effective nonpharmacological adjuncts to existing ASD interventions.

  • Open Access

    Cutaneous Mast Cells Contribute to the Analgesic Effect of Manual Therapy on CCD Rats

    by Jiayang Yu, Pingping Sun, Dong Xie, Xinyu Zeng, Xili Chang, Min Fang, Wuquan Sun, Qingguang Zhu, Chongjie Yao

    Background: Lumbar disc herniation (LDH) commonly induces low back and leg pain. Manual therapy (MT) is effective in relieving such pain clinically, but its mechanism remains unclear. Given that acupoint regions are enriched with mast cells that respond to mechanical stimulation, this study explored whether MT alleviates CCD‐evoked neuropathic pain and its association with the modulation of cutaneous mast cells. Methods: Sprague‐Dawley (SD) rats were randomized into sham, chronic compression of dorsal root ganglion (CCD), MT, and mast cell inhibition (MCI) groups. After CCD modeling, MT was administered at BL57 starting on day 4 for 14 days, while MCI received acupoint cromolyn sodium injection. Paw withdrawal threshold (PWT) was measured. Mast cell activation was assessed using immunofluorescence and toluidine blue staining. Calcitonin gene‐related peptide (CGRP), substance P (SP), Piezo1, and Piezo2 were determined via immunofluorescence; inflammatory cytokines and neurotransmitters by ELISA; expression of MAPK, Piezo1, and Piezo2 by qRT‐PCR. MAPK expressions were also detected by Western blot. Results: CCD reduced PWT from day 3, whereas MT significantly restored PWT from day 11. In skin, CCD increased mast cell activation, CGRP, SP, tumor necrosis factor (TNF)‐α, interleukin (IL)‐6, IL‐1β, 5‐hydroxytryptamine (5‐HT), and histamine (HA), all of which were attenuated by both interventions. In DRG, CCD elevated p‐ERK, p‐JNK, and p‐p38 MAPK without altering total MAPK expression, and both interventions suppressed MAPK phosphorylation. Piezo2 was upregulated in CCD and reduced by MT and MCI in both tissues. In skin, Piezo1 remained unchanged, while in DRG, CCD downregulated Piezo1 significantly. Conclusion: MT can relieve CCD‐induced mechanical allodynia, an effect associated with inhibited cutaneous mast cell activation, attenuated peripheral neuroinflammation, and reduced MAPK hyperphosphorylation in the DRG.

  • Open Access

    Effect of Physical Activity on Chronic Widespread Pain: Insights From Meta-Analysis and Two-Sample Mendelian Randomization

    by Chongjie Yao, Yuchen Zhang, Sizheng Steven Zhao, Jun Ren, Pingping Sun, Lingjun Kong, Jiming Tao, Jingxian Li, Min Fang, Qingguang Zhu

    Background: Chronic widespread pain (CWP) is a core symptom of fibromyalgia that is associated with significant morbidity and mortality. Despite the widespread recommendation for physical activity (PA) in management, the heterogeneity of PA prescriptions limits the in-depth evaluation of its efficacy. By triangulating clinical interventional evidence with human genetic evidence, the aim of this study was to investigate the role of influencing factors such as PA mode, course of treatment, and intensity on PA in the prevention and treatment of CWP. Methods: Ten international and regional databases were searched for articles published between January 2014 and July 2024. Randomized control trials with CWP or fibromyalgia as an entry criterion and PA as an intervention were included. Meta-analyses were performed using fixed- or random-effects models based on heterogeneity, and subgroup analyses were conducted. Mendelian randomization (MR) was used to estimate the effects of the genetic variants linked to PA intensity on CWP risk. Results: The analysis included 11 studies with 540 participants. PA effectively improved pain perception (MD: − 1.47; 95% CI: − 2.23, − 0.72), depression (MD: − 4.77; 95% CI: − 7.40, − 2.14), and overall quality of life (SMD: − 1.43; 95% CI: − 2.16, − 0.69). MR analysis revealed that several PA intensities were associated with reduced susceptibility to CWP: walking for pleasure (OR: 0.950; 95% CI: 0.934– 0.966), light do-it-yourself (DIY) (OR: 0.976; 95% CI: 0.961– 0.992), strenuous sports (OR: 0.923; 95% CI: 0.880– 0.967), and other exercises (OR: 0.957; 95% CI: 0.942– 0.973). Conclusion: PA interventions are beneficial for reducing pain perception and mood disorders and enhancing the quality of life of patients with CWP. A treatment course of approximately three months is preferable, with Ba-Duan-Jin potentially more effective than other PAs, and high-intensity PA offers the most significant protective effect against CWP.


  • Open Access

    Long-term follow-up of the treatment for severe COVID-19 with qigong exercise and acupressure: A randomized controlled trial

    by Shuting Liu, Ranran Zhu, Chongjie Yao, Chao Zhan, Jinxiang Wang, Min Fang, Lei Fang


  • Open Access

    Clinical Evidence for the Effects of Manual Therapy on Cancer Pain: A Systematic Review and Meta-Analysis

    by Chongjie Yao, Yanbin Cheng, Qingguang Zhu, Zhizhen Lv, Lingjun Kong, Min Fang

    Objective. This meta-analysis aimed to evaluate the effects of manual therapy (MT) on cancer pain, so as to provide clinical evidence for application. Methods. Five English and Chinese databases were searched until February 29, 2020, for randomized controlled trials (RCTs) of MT for cancer pain. Articles published in the English or Chinese language were included. Two authors independently reviewed all articles and extracted the data, and any disagreements in the above process were discussed with other reviewers until the authors reached consensus. Review Manager 5.3 was used to calculate the effect size and 95% confidence intervals. This review was registered in PROSPERO, number CRD42020172053. Results. The intensity of cancer pain is our primary outcome measure, and compared with standard care, MT can significantly relieve the pain of patients with cancer (SMD, 0.63; 95% CI [0.18, 1.08]; ); the effects of MT plus active activity were significantly different from AT alone (SMD, 0.79; 95% CI [0.28, 1.30]; ); there was no statistical difference in the efficacy of MT and AT alone (SMD, -0.24; 95% CI [-1.09, 0.62]; ). In other related symptoms, the above evidence cannot support that MT had a good effect on fatigue (SMD, 0.77; 95% CI [-0.09, 1.63]; ), nausea (SMD, 0.24; 95% CI [-0.00, 0.48]; ), anxiety (SMD, 0.76; 95 % CI [-0.32, 1.84]; ), and depression (SMD, 0.67; 95 % CI [-0.28, 1.62]; ); however, MT intervention can improve physical function (n = 271; SMD, 0.35; 95 % CI [-0.04, 0.74]; ) and global well-being (SMD, 0.50; 95 % CI [0.02, 0.98]; ). In addition, MT had a significant effect on pain relief (SMD, 0.52; 95% CI [0.03, 1.01]; ) and improvement of physical function (SMD, 0.28; 95% CI [0.02, 0.53]; <svg xmlns:xlink="http://www.w3.org/1999/xlink"...